Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Glenmark gets US FDA approval for alclometasone

This article was originally published in Scrip

Executive Summary

Glenmark Generics has received US FDA approval for alclometasone dipropionate ointment 0.05%, a generic version of GlaxoSmithKline's Aclovate ointment. The product is used for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Glenmark expects to start marketing the product in the US immediately.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts